Idorsia successfully completes an upsized offering of shares – funding the company to overall profitability
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY,...
Pharmaceutical
Palisade Bio Announces Cancellation of Special Meeting of Stockholders
Carlsbad, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a...
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in...
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a...
Procedure of the Annual General Meeting
ANNOUNCEMENT NO. 294 9 October 2025 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was...
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical...
Idorsia launches an offering of registered shares – to fund the company to overall profitability
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY,...
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando
Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina Subspecialty DayCAMBRIDGE,...
IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa
Partners will advance end-to-end development of biologics for regionally prioritized diseases starting with Mpox and HIV CAIRO, EGYPT; BERLIN, GERMANY;...
Genflow Biosciences PLC Announces Update on Animal Health Program
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
BioNxt Solutions Provides Update To Annual General Meeting Matters Due To Canadian Postal Strike And IR Activities
VANCOUVER, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) wishes to...
Addison Care Debuts at athenahealth 2025 Thrive Conference: 3D Virtual Caregiver Tackles Global Healthcare Crisis of Non-Adherence and Workforce Shortages
LAS CRUCES, NEW MEXICO / ACCESS Newswire / October 9, 2025 / The healthcare industry is approaching a breaking point....
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it...
NHI Announces Third Quarter 2025 Earnings Release and Conference Call Dates
MURFREESBORO, TN / ACCESS Newswire / October 9, 2025 / National Health Investors, Inc. (NYSE:NHI) announced details for the release...
AHIMA 2025: The 20 Must-See Exhibitors With Top User Scores and Future-Focused HIM Innovations Identified by Black Book Surveys
Highlighting the Solutions Transforming Data Accuracy, Automation, and AI-Driven Revenue Integrity at the Minneapolis Convention Center, October 12–14, 2025 MINNEAPOLIS,...
CareChoice Recognized With “Outstanding Growth Award” by HHAeXchange at 2025 PA Customer Summit
Delivering over two million hours of care while creating meaningful jobs for family caregivers. PHILADELPHIA, PA / ACCESS Newswire /...
TextQL Launches Healthcare Vertical with Marquee Client and Executive Advisory Board
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- TextQL today launched TextQL Healthcare, a game-changing vertical that brings the company's industry-leading AI...
OUTCOMES4ME NAMED TO TIME’S LIST OF THE BEST INVENTIONS OF 2025
BOSTON, Oct. 9, 2025 /PRNewswire/ -- Today, Outcomes4Me announced it has been named to TIME's Best Inventions of 2025 list....
BioNJ’s 13th Annual C-Suite Summit: A Premier Lineup & Bold Agenda
TRENTON, N.J., Oct. 9, 2025 /PRNewswire/ -- BioNJ will host its Thirteenth Annual C-Suite Summit on Thursday, October 30, 2025,...
Can Neuroimaging Save Psychedelic Drug Development? Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how neuroimaging technologies like PET, fMRI and multimodal approaches provide objective insights into brain mechanisms...